American Trust Abb Vie Inc. Transaction History

American Trust

$1.15 Billion
Q3 2024

A detailed history of American Trust transactions in Abb Vie Inc. stock. As of the latest transaction made, American Trust holds 6,691 shares of ABBV stock, worth $1.19 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

6,691

Previous 6,468 3.45%

Holding current value

$1.19 Million

Previous $1.11 Million 19.12%

% of portfolio

0.12%

Previous 0.1%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 29, 2024	BUY	$163.84 - $199.33 $36,536 - $44,450	223 Added 3.45%	6,691 $1.32 Million
Q2 2024 Sep 11, 2024	SELL	$154.79 - $180.76 $108,043 - $126,170	-698 Reduced 9.74%	6,468 $1.11 Million
Q1 2024 Jun 11, 2024	BUY	$159.82 - $182.1 $57,055 - $65,009	357 Added 5.24%	7,166 $1.3 Million
Q4 2023 Feb 21, 2024	BUY	$137.6 - $154.97 $45,132 - $50,830	328 Added 5.06%	6,809 $1.06 Million
Q3 2023 Nov 15, 2023	SELL	$133.59 - $154.65 $106,872 - $123,720	-800 Reduced 10.99%	6,481 $966,000
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $28,489 - $35,453	-215 Reduced 2.87%	7,281 $980,000
Q1 2023 May 22, 2023	BUY	$144.61 - $166.54 $18,654 - $21,483	129 Added 1.75%	7,496 $1.19 Million
Q4 2022 Feb 16, 2023	BUY	$138.31 - $165.87 $55,462 - $66,513	401 Added 5.76%	7,367 $1.19 Million
Q3 2022 Dec 02, 2022	SELL	$134.21 - $153.93 $17,447 - $20,010	-130 Reduced 1.83%	6,966 $935,000
Q2 2022 Oct 03, 2022	SELL	$137.62 - $174.96 $62,204 - $79,081	-452 Reduced 5.99%	7,096 $1.09 Million
Q1 2022 Jun 08, 2022	BUY	$131.98 - $163.75 $55,431 - $68,775	420 Added 5.89%	7,548 $1.22 Million
Q4 2021 Mar 17, 2022	BUY	$107.43 - $135.93 $765,761 - $968,909	7,128 New	7,128 $965,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Trust, based on Form 13F filings with the SEC.

News

Stay updated on American Trust with notifications on news.

Account